All stock lists
Ethos Technologies Inc. (NASDAQ:LIFE)
US · Delayed Price · Currency is USD
Financial Services · Insurance - Brokers
43.10-0.43 (-0.99%)
Insider Score
––Not scored
LIFE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LIFE analyst forecast
LIFE analyst consensus
Moderate Buy5 ratings
Buy 4 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
LIFE 12-month price target
$43.00+2.0% upsideaverage of 1 firm
$43.00High
$43.00Low
Best analysts covering LIFE
No firm covering LIFE has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
LIFE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Goldman Sachs | — | $43.00 | +8.6% | — | 2026-10-14 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-10-12 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-10-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-08-04 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-04 |
| — | Baird | Outperform | — | — | Reiterated | 2026-08-04 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-04 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-07-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-08 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-05-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-14 |
| — | HC Wainwright& Co. | Buy | — | — | Reiterated | 2024-05-03 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-03-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-02-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-10 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-07-21 |
| — | Oppenheimer | Perform | — | — | Downgraded | 2023-07-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-23 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-04-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-03-02 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-07-21 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-05-18 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2022-05-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-11-11 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-09-14 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2021-09-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-09-13 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2021-03-24 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-03-16 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2020-08-17 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2020-03-27 |
| — | Citigroup | Neutral | — | — | Upgraded | 2018-08-17 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2018-08-15 |
| — | Citigroup | Sell | — | — | Downgraded | 2018-05-15 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2018-02-14 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2016-12-14 |
| — | Citigroup | Neutral | — | — | Reiterated | 2016-08-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2016-08-11 |
| — | William Blair | Market Perform | — | — | Downgraded | 2016-03-31 |
| — | Baird | Neutral | — | — | Downgraded | 2013-08-01 |
| — | Credit Agricole | Underperform | — | — | Downgraded | 2013-05-21 |
| — | Jefferies | Hold | — | — | Downgraded | 2013-05-06 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2013-04-16 |
| — | Maxim Group | Hold | — | — | Downgraded | 2013-04-15 |
| — | Goldman Sachs | Neutral | — | — | Upgraded | 2013-04-15 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2013-04-15 |
| — | Citigroup | Neutral | — | — | Downgraded | 2013-03-25 |
| — | Cowen & Co. | Neutral | — | — | Downgraded | 2013-03-21 |
| — | Leerink Swann | Market Perform | — | — | Downgraded | 2013-02-05 |
| — | Credit Agricole | Outperform | — | — | Reiterated | 2013-02-05 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2013-02-05 |
| — | ISI Group | Neutral | — | — | Reiterated | 2013-02-05 |
| — | UBS | Neutral | — | — | Downgraded | 2013-01-28 |
| — | William Blair | Market Perform | — | — | Downgraded | 2013-01-22 |
| — | Jefferies | Buy | — | — | Reiterated | 2012-11-02 |
| — | Jefferies | Buy | — | — | Reiterated | 2012-08-01 |
LIFE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-25 | 0.38 | 0.42 | $108.4M | $110.1M |
| 2026-05-06 | 0.46 | -3.57 | $145.0M | $193.1M |
| 2026-08-03 | 0.05 | 0.30 | $117.3M | $189.6M |
| 2026-11-02 | 0.08 | 0.00 | $169.0M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.